Results 131 to 140 of about 34,123 (218)
JPGN Reports, Volume 7, Issue 3, Page 477-478, August 2026.
Kavya Kurkal, Girish L. Gupte
wiley +1 more source
Intermittent exogenous ketosis stimulates erythropoietin, with greater EPO response and elevated ferritin in females but no significant changes in circulating hemoglobin or red blood cell count at 2 weeks. Abstract Exogenous ketosis may stimulate erythropoietin (EPO), yet its impact on erythropoiesis, iron metabolism, and potential sex‐specific ...
Henrik Holm Thomsen +3 more
wiley +1 more source
The identification of a patient carrying a novel homozygous p.(Gln206Ter) POC5 variant revealed a metabolic phenotype associated with POC5 deficiency. POC5 deficiency disrupts centriolar architecture and ciliary organization, leading to impaired proliferation, premature cellular senescence, and reduced insulin signaling.
Valeria Pistorio +10 more
wiley +1 more source
Compound heterozygous mutations in CC2D2A cause Meckel-Gruber syndrome: a case report and review of the literature. [PDF]
Liu L, Lv Y, Zhou X.
europepmc +1 more source
Prenatal Diagnosis of Renal Cysts and Diabetes Syndrome (RCAD): A Case Report. [PDF]
Manasar-Dyrbuś M +4 more
europepmc +1 more source
Endocannabinoid System-Related Inflammation and Progression of Autosomal Dominant Polycystic Kidney Disease. [PDF]
Simankowicz P +5 more
europepmc +1 more source
Discussion on Polycystic Disease of the Kidneys [PDF]
openaire +5 more sources
Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease. [PDF]
Lanktree MB +18 more
europepmc +1 more source
Emerging roles of ATP citrate lyase in kidney diseases: from pathogenic driver to therapeutic target. [PDF]
Wei M +7 more
europepmc +1 more source

